HIV

Alan Mozes FRIDAY, May 19, 2023 (HealthDay News) -- Some HIV patients are naturally able to keep the virus fully in check without any medicinal help, a…

Immune checkpoint inhibitors showed activity among people with HIV and various…

Lori Solomon FRIDAY, May 12, 2023 (HealthDay News) -- Higher rates of HIV diagnoses are seen among users of U.K. mental health services versus the…

New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV…

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersA Delaware jury on Tuesday cleared Gilead Sciences of U.S. government…

(through site-specific expanded access investigational new drug applications). The drug was originally developed and approved for the treatment of…

Gene-editing therapy aimed at two targets -- HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells -- can effectively eliminate HIV infection, new…

Decades after its discovery, the emerging view of idiopathic CD4 lymphocytopenia (ICL) --…

Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto via…

Elana Gotkine MONDAY, May 1, 2023 (HealthDay News) -- HIV status seems not to affect treatment outcomes among patients receiving tecovirimat for mpox,…